which could be recorded and studied. Surely we should settle down to the scientific study of the various patterns of abdominal wound closure in use and the individual techniques of the surgeons who use them. 'As a result, we would be able to communicate with each other on our experiences of wound closure without arousing anger or just frank disbelief; hernia repair needs a similar approach. The recognition of the necessary criteria to make wound closure safe and comfortable would rapidly follow. Perhaps a method close to the ideal would be found and gain recognition within a decade. (1979)BritishJournalof Surgery(in press) Endocrine hypofunction following radiotherapy From Mr M A Coe Radiotherapy Department, Westminster Hospital, London SWI Dear Sir, The minimum information needed to compare one radiotherapy treatment course with another is the total dose, number of fractions, and total treatment time. Even then, such comparisons may not be entirely valid.
The interesting review by Shalet & Beardwell entitled 'Endocrine consequences of treatment of malignant disease in childhood' (January Journal, p 39) contains eight statements of radiation dose, and in half of them only the total dose is given. None gives the full description of totar dose/number of fractions/total time. I believe that the Manchester'experience of endocrine hypofunction following radiotherapy has not been reproduced in every centre. This article as it stands does not allow the reader to compare the Manchester techniques with others, or persuade him to change his own practice. Yours sincerely MACOE 20 March 1979 A copy of this letter was sent to Drs Shalet and Beardwell whose reply appears below: Dear Sir, We completely agree with the point raised by Mr M A Coe that the effect of a radiotherapy treatment will depend on many factors including the total dose, number of fractions and total treatment time. We (January, p 39) had to review a considerable field in a relatively short paper and therefore full details of each radiotherapy treatment were not mentioned. However, on each occasion that a radiation dose was quoted in the article there is a reference attached, and this will in many cases supply further information concerning the radiotherapy treatment.
Mr Coe also mentions disagreement amongst different groups about endocrine hypofunction following radiotherapy. Contention has only existed in one area and that is whether or not abnormalities of growth hormone (GH) secretion occur in children who previously received prophylactic cranial irradiation for acute lymphatic leukaemia. Indeed, Swift et aJ. (1978) have suggested that the abnormality of GH secretion described by us (Shalet et al. 1977) in leukaemic children may only be a Manchester phenomenon. Similar abnormalities, however, have been found in such children in Glasgow (Barter et al. 1978 ), Bethesda (Oliff et aJ. 1979 , Arkansas (Dickinson et al. 1978) and Italy (Schiliro et al. 1976) . We believe that the discrepancy between the GH responses to provocative stimuli reported by different groups is almost certainly due to the variation in the effective biological dose of irradiation reaching the hypothalamic-pituitary axis. As already indicated, the latter will be influenced by the total dose, number of fractions and total treatment time as well as the method of irradiation and the fraction size. 
